Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 216

1.

Platelets Are Critical Key Players in Sepsis.

Vardon-Bounes F, Ruiz S, Gratacap MP, Garcia C, Payrastre B, Minville V.

Int J Mol Sci. 2019 Jul 16;20(14). pii: E3494. doi: 10.3390/ijms20143494. Review.

2.

Platelet Activation Is Limited during Transcatheter Aortic Valve Implantation in Patients on Aspirin Monotherapy and without per Procedural Clinical Complications.

Dumonteil N, Levade M, Garcia C, Lhermusier T, Series J, Le Faouder P, Marcheix B, Payrastre B, Carrié D, Sié P.

TH Open. 2019 May 30;3(2):e146-e152. doi: 10.1055/s-0039-1692142. eCollection 2019 Apr.

3.

Effects of Estrogens on Platelets and Megakaryocytes.

Dupuis M, Severin S, Noirrit-Esclassan E, Arnal JF, Payrastre B, Valéra MC.

Int J Mol Sci. 2019 Jun 25;20(12). pii: E3111. doi: 10.3390/ijms20123111. Review.

4.

Effects of conjugated estrogen and bazedoxifene on hemostasis and thrombosis in mice.

Noirrit E, Buscato M, Dupuis M, Payrastre B, Fontaine C, Arnal JF, Valera MC.

Endocr Connect. 2019 May 1. pii: EC-19-0079.R1. doi: 10.1530/EC-19-0079. [Epub ahead of print]

5.

First description of an IgM monoclonal antibody causing αII b β3 integrin activation and acquired Glanzmann thrombasthenia associated with macrothrombocytopenia.

Pillois X, Guy A, Choquet É, James C, Tuffigo M, Viallard JF, Garcia C, Bordet JC, Jandrot-Perrus M, Payrastre B, Fiore M.

J Thromb Haemost. 2019 May;17(5):795-802. doi: 10.1111/jth.14424. Epub 2019 Apr 19.

PMID:
30868743
6.

Differences and similarities in ibrutinib and acalabrutinib effects on platelet functions.

Series J, Garcia C, Levade M, Viaud J, Sié P, Ysebaert L, Payrastre B.

Haematologica. 2019 Feb 28. pii: haematol.2018.207183. doi: 10.3324/haematol.2018.207183. [Epub ahead of print]

7.

Class I PI3Ks in arterial thrombosis.

Laurent PA, Payrastre B, Gratacap MP.

Aging (Albany NY). 2019 Feb 24;11(5):1321-1322. doi: 10.18632/aging.101841. No abstract available.

8.

Predictive Value of Susceptibility Vessel Sign for Arterial Recanalization and Clinical Improvement in Ischemic Stroke.

Darcourt J, Withayasuk P, Vukasinovic I, Michelozzi C, Bellanger G, Guenego A, Adam G, Roques M, Januel AC, Tall P, Meyrignac O, Rousseau V, Garcia C, Albucher JF, Payrastre B, Bonneville F, Olivot JM, Cognard C.

Stroke. 2019 Feb;50(2):512-515. doi: 10.1161/STROKEAHA.118.022912.

PMID:
30602358
9.

Deciphering biased inverse agonism of cangrelor and ticagrelor at P2Y12 receptor.

Garcia C, Maurel-Ribes A, Nauze M, N'Guyen D, Martinez LO, Payrastre B, Sénard JM, Galés C, Pons V.

Cell Mol Life Sci. 2019 Feb;76(3):561-576. doi: 10.1007/s00018-018-2960-3. Epub 2018 Nov 7.

PMID:
30406277
10.

Impact of PI3Kα (Phosphoinositide 3-Kinase Alpha) Inhibition on Hemostasis and Thrombosis.

Laurent PA, Hechler B, Solinhac R, Ragab A, Cabou C, Anquetil T, Severin S, Denis CV, Mangin PH, Vanhaesebroeck B, Payrastre B, Gratacap MP.

Arterioscler Thromb Vasc Biol. 2018 Sep;38(9):2041-2053. doi: 10.1161/ATVBAHA.118.311410.

PMID:
30354258
11.

Platelet activation and prothrombotic properties in a mouse model of peritoneal sepsis.

Vardon Bounes F, Mémier V, Marcaud M, Jacquemin A, Hamzeh-Cognasse H, Garcia C, Series J, Sié P, Minville V, Gratacap MP, Payrastre B.

Sci Rep. 2018 Sep 10;8(1):13536. doi: 10.1038/s41598-018-31910-8.

12.

Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults.

Piel-Julian ML, Mahévas M, Germain J, Languille L, Comont T, Lapeyre-Mestre M, Payrastre B, Beyne-Rauzy O, Michel M, Godeau B, Adoue D, Moulis G; CARMEN investigators group.

J Thromb Haemost. 2018 Sep;16(9):1830-1842. doi: 10.1111/jth.14227. Epub 2018 Aug 12.

PMID:
29978544
13.

Effect of estetrol, a selective nuclear estrogen receptor modulator, in mouse models of arterial and venous thrombosis.

Valéra MC, Noirrit-Esclassan E, Dupuis M, Fontaine C, Lenfant F, Briaux A, Cabou C, Garcia C, Lairez O, Foidart JM, Payrastre B, Arnal JF.

Mol Cell Endocrinol. 2018 Dec 5;477:132-139. doi: 10.1016/j.mce.2018.06.010. Epub 2018 Jun 19.

PMID:
29928930
14.

Profiling of phosphoinositide molecular species in human and mouse platelets identifies new species increasing following stimulation.

Mujalli A, Chicanne G, Bertrand-Michel J, Viars F, Stephens L, Hawkins P, Viaud J, Gaits-Iacovoni F, Severin S, Gratacap MP, Terrisse AD, Payrastre B.

Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Sep;1863(9):1121-1131. doi: 10.1016/j.bbalip.2018.06.009. Epub 2018 Jun 12.

PMID:
29902570
15.

The lipid products of phosphoinositide 3-kinase isoforms in cancer and thrombosis.

Anquetil T, Payrastre B, Gratacap MP, Viaud J.

Cancer Metastasis Rev. 2018 Sep;37(2-3):477-489. doi: 10.1007/s10555-018-9735-z. Review.

PMID:
29868934
16.

Phosphoinositides regulate the TCR/CD3 complex membrane dynamics and activation.

Chouaki-Benmansour N, Ruminski K, Sartre AM, Phelipot MC, Salles A, Bergot E, Wu A, Chicanne G, Fallet M, Brustlein S, Billaudeau C, Formisano A, Mailfert S, Payrastre B, Marguet D, Brasselet S, Hamon Y, He HT.

Sci Rep. 2018 Mar 21;8(1):4966. doi: 10.1038/s41598-018-23109-8.

17.

Acute coronary syndrome remodels the antiplatelet aggregation properties of HDL particle subclasses.

Garcia C, Montée N, Faccini J, Series J, Meilhac O, Cantero AV, Le Faouder P, Elbaz M, Payrastre B, Vindis C.

J Thromb Haemost. 2018 May;16(5):933-945. doi: 10.1111/jth.14003. Epub 2018 Apr 18.

PMID:
29543379
18.

The antagonist properties of Bazedoxifene after acute treatment are shifted to stimulatory action after chronic exposure in the liver but not in the uterus.

Buscato M, Fontaine C, Fabre A, Vinel A, Valera MC, Noirrit E, Guillaume M, Payrastre B, Métivier R, Arnal JF.

Mol Cell Endocrinol. 2018 Sep 5;472:87-96. doi: 10.1016/j.mce.2017.11.022. Epub 2017 Nov 26.

PMID:
29183806
19.

Vps34 PI 3-kinase inactivation enhances insulin sensitivity through reprogramming of mitochondrial metabolism.

Bilanges B, Alliouachene S, Pearce W, Morelli D, Szabadkai G, Chung YL, Chicanne G, Valet C, Hill JM, Voshol PJ, Collinson L, Peddie C, Ali K, Ghazaly E, Rajeeve V, Trichas G, Srinivas S, Chaussade C, Salamon RS, Backer JM, Scudamore CL, Whitehead MA, Keaney EP, Murphy LO, Semple RK, Payrastre B, Tooze SA, Vanhaesebroeck B.

Nat Commun. 2017 Nov 27;8(1):1804. doi: 10.1038/s41467-017-01969-4.

20.

The importance of blood platelet lipid signaling in thrombosis and in sepsis.

Vardon Bounes F, Mujalli A, Cenac C, Severin S, Le Faouder P, Chicanne G, Gaits-Iacovoni F, Minville V, Gratacap MP, Payrastre B.

Adv Biol Regul. 2018 Jan;67:66-73. doi: 10.1016/j.jbior.2017.09.011. Epub 2017 Sep 29. Review.

PMID:
28993230
21.

Expression of the neuropathy-associated MTMR2 gene rescues MTM1-associated myopathy.

Raess MA, Cowling BS, Bertazzi DL, Kretz C, Rinaldi B, Xuereb JM, Kessler P, Romero NB, Payrastre B, Friant S, Laporte J.

Hum Mol Genet. 2017 Oct 1;26(19):3736-3748. doi: 10.1093/hmg/ddx258.

PMID:
28934386
22.

A dual role for the class III PI3K, Vps34, in platelet production and thrombus growth.

Valet C, Levade M, Chicanne G, Bilanges B, Cabou C, Viaud J, Gratacap MP, Gaits-Iacovoni F, Vanhaesebroeck B, Payrastre B, Severin S.

Blood. 2017 Nov 2;130(18):2032-2042. doi: 10.1182/blood-2017-04-781641. Epub 2017 Sep 13.

23.

Protein-Lipid Interaction by Fluorescence (PLIF) to Characterize and Screen for Inhibitors of Protein-Phosphoinositide Interactions.

Ceccato L, Mansat M, Payrastre B, Gaits-Iacovoni F, Viaud J.

Curr Protoc Protein Sci. 2017 Aug 1;89:19.31.1-19.31.10. doi: 10.1002/cpps.35.

PMID:
28762494
24.

Acetylsalicylic acid differentially limits the activation and expression of cell death markers in human platelets exposed to Staphylococcus aureus strains.

Chabert A, Damien P, Verhoeven PO, Grattard F, Berthelot P, Zeni F, Panicot-Dubois L, Robert S, Dignat-George F, Eyraud MA, Pozzetto B, Payrastre B, Cognasse F, Garraud O, Hamzeh-Cognasse H.

Sci Rep. 2017 Jul 17;7(1):5610. doi: 10.1038/s41598-017-06024-2.

25.

Effect of chronic estradiol plus progesterone treatment on experimental arterial and venous thrombosis in mouse.

Valéra MC, Noirrit-Esclassan E, Dupuis M, Buscato M, Vinel A, Guillaume M, Briaux A, Garcia C, Benoit T, Lairez O, Fontaine C, Payrastre B, Arnal JF.

PLoS One. 2017 May 9;12(5):e0177043. doi: 10.1371/journal.pone.0177043. eCollection 2017.

26.

Inhibition of PIKfyve prevents myocardial apoptosis and hypertrophy through activation of SIRT3 in obese mice.

Tronchere H, Cinato M, Timotin A, Guitou L, Villedieu C, Thibault H, Baetz D, Payrastre B, Valet P, Parini A, Kunduzova O, Boal F.

EMBO Mol Med. 2017 Jun;9(6):770-785. doi: 10.15252/emmm.201607096.

27.

Mass Assays to Quantify Bioactive PtdIns3P and PtdIns5P During Autophagic Responses.

Viaud J, Chicanne G, Solinhac R, Hnia K, Gaits-Iacovoni F, Payrastre B.

Methods Enzymol. 2017;587:293-310. doi: 10.1016/bs.mie.2016.09.061. Epub 2016 Nov 18.

PMID:
28253962
28.

NF-κB Links TLR2 and PAR1 to Soluble Immunomodulator Factor Secretion in Human Platelets.

Damien P, Cognasse F, Payrastre B, Spinelli SL, Blumberg N, Arthaud CA, Eyraud MA, Phipps RP, McNicol A, Pozzetto B, Garraud O, Hamzeh-Cognasse H.

Front Immunol. 2017 Feb 6;8:85. doi: 10.3389/fimmu.2017.00085. eCollection 2017.

29.

Trans-inhibition of activation and proliferation signals by Fc receptors in mast cells and basophils.

Malbec O, Cassard L, Albanesi M, Jönsson F, Mancardi D, Chicanne G, Payrastre B, Dubreuil P, Vivier E, Daëron M.

Sci Signal. 2016 Dec 20;9(459):ra126. doi: 10.1126/scisignal.aag1401.

PMID:
27999175
30.

Nuclear imaging of thrombosis in small animal.

Valéra MC, Payrastre B, Lairez O.

Platelets. 2017 Nov;28(7):643-648. doi: 10.1080/09537104.2016.1246720. Epub 2016 Nov 29. Review.

PMID:
27897087
31.

Functional Characterization and Rescue of a Deep Intronic Mutation in OCRL Gene Responsible for Lowe Syndrome.

Rendu J, Montjean R, Coutton C, Suri M, Chicanne G, Petiot A, Brocard J, Grunwald D, Pietri Rouxel F, Payrastre B, Lunardi J, Dorseuil O, Marty I, Fauré J.

Hum Mutat. 2017 Feb;38(2):152-159. doi: 10.1002/humu.23139. Epub 2016 Nov 21.

PMID:
27790796
32.

Expression of myotubularins in blood platelets: Characterization and potential diagnostic of X-linked myotubular myopathy.

Mansour R, Severin S, Xuereb JM, Gratacap MP, Laporte J, Buj-Bello A, Tronchère H, Payrastre B.

Biochem Biophys Res Commun. 2016 Jul 29;476(3):167-73. doi: 10.1016/j.bbrc.2016.04.127. Epub 2016 May 4.

PMID:
27155155
33.

PLIF: A rapid, accurate method to detect and quantitatively assess protein-lipid interactions.

Ceccato L, Chicanne G, Nahoum V, Pons V, Payrastre B, Gaits-Iacovoni F, Viaud J.

Sci Signal. 2016 Mar 29;9(421):rs2. doi: 10.1126/scisignal.aad4337.

PMID:
27025878
34.

Cdc42-dependent F-actin dynamics drive structuration of the demarcation membrane system in megakaryocytes.

Antkowiak A, Viaud J, Severin S, Zanoun M, Ceccato L, Chicanne G, Strassel C, Eckly A, Leon C, Gachet C, Payrastre B, Gaits-Iacovoni F.

J Thromb Haemost. 2016 Jun;14(6):1268-84. doi: 10.1111/jth.13318. Epub 2016 Apr 21.

35.

Targeting Kinases in Cancer Therapies: Adverse Effects on Blood Platelets.

Levade M, Severin S, Gratacap MP, Ysebaert L, Payrastre B.

Curr Pharm Des. 2016;22(16):2315-22. Review.

PMID:
26916020
36.

The class I phosphoinositide 3-kinases α and β control antiphospholipid antibodies-induced platelet activation.

Terrisse AD, Laurent PA, Garcia C, Gratacap MP, Vanhaesebroeck B, Sié P, Payrastre B.

Thromb Haemost. 2016 Jun 2;115(6):1138-46. doi: 10.1160/TH15-08-0661. Epub 2016 Jan 28.

PMID:
26818901
37.

PI5P Triggers ICAM-1 Degradation in Shigella Infected Cells, Thus Dampening Immune Cell Recruitment.

Boal F, Puhar A, Xuereb JM, Kunduzova O, Sansonetti PJ, Payrastre B, Tronchère H.

Cell Rep. 2016 Feb 2;14(4):750-759. doi: 10.1016/j.celrep.2015.12.079. Epub 2016 Jan 14.

38.

ATP-binding cassette transporter 1 (ABCA1) deficiency decreases platelet reactivity and reduces thromboxane A2 production independently of hematopoietic ABCA1.

Lhermusier T, Severin S, Van Rothem J, Garcia C, Bertrand-Michel J, Le Faouder P, Hechler B, Broccardo C, Couvert P, Chimini G, Sié P, Payrastre B.

J Thromb Haemost. 2016 Mar;14(3):585-95. doi: 10.1111/jth.13247. Epub 2016 Feb 17.

39.

The role of class I, II and III PI 3-kinases in platelet production and activation and their implication in thrombosis.

Valet C, Severin S, Chicanne G, Laurent PA, Gaits-Iacovoni F, Gratacap MP, Payrastre B.

Adv Biol Regul. 2016 May;61:33-41. doi: 10.1016/j.jbior.2015.11.008. Epub 2015 Dec 2. Review.

PMID:
26714793
40.

Inactivation of the Class II PI3K-C2β Potentiates Insulin Signaling and Sensitivity.

Alliouachene S, Bilanges B, Chicanne G, Anderson KE, Pearce W, Ali K, Valet C, Posor Y, Low PC, Chaussade C, Scudamore CL, Salamon RS, Backer JM, Stephens L, Hawkins PT, Payrastre B, Vanhaesebroeck B.

Cell Rep. 2015 Dec 1;13(9):1881-94. doi: 10.1016/j.celrep.2015.10.052. Epub 2015 Nov 19.

41.

[Phosphoinositides: the lipids coordinating cell dynamics].

Viaud J, Payrastre B.

Med Sci (Paris). 2015 Nov;31(11):996-1005. doi: 10.1051/medsci/20153111014. Epub 2015 Nov 17. Review. French.

42.

Platelet Adhesion and Thrombus Formation in Whole Blood at Arterial Shear Rate at the End of Pregnancy.

Valéra MC, Parant O, Cenac C, Arnaud C, Gallini A, Hamdi S, Sié P, Arnal JF, Payrastre B.

Am J Reprod Immunol. 2015 Dec;74(6):533-41. doi: 10.1111/aji.12433. Epub 2015 Oct 4.

PMID:
26435170
43.

Phosphoinositides: Important lipids in the coordination of cell dynamics.

Viaud J, Mansour R, Antkowiak A, Mujalli A, Valet C, Chicanne G, Xuereb JM, Terrisse AD, Séverin S, Gratacap MP, Gaits-Iacovoni F, Payrastre B.

Biochimie. 2016 Jun;125:250-8. doi: 10.1016/j.biochi.2015.09.005. Epub 2015 Sep 25. Review.

PMID:
26391221
44.

Protective Hematopoietic Effect of Estrogens in a Mouse Model of Thrombosis: Respective Roles of Nuclear Versus Membrane Estrogen Receptor α.

Valéra MC, Fontaine C, Lenfant F, Cabou C, Guillaume M, Smirnova N, Kim SH, Chambon P, Katzenellenbogen JA, Katzenellenbogen BS, Payrastre B, Arnal JF.

Endocrinology. 2015 Nov;156(11):4293-301. doi: 10.1210/en.2015-1522. Epub 2015 Aug 17.

45.

[Association of estrogens and selective estrogens receptors modulators: towards a renewal of the hormonal treatment?].

Valéra MC, Chantalat E, Vinel A, Benoit T, Guillaume M, Game X, Gourdy P, Trémollières F, Payrastre B, Arnal JF.

Presse Med. 2015 Jul-Aug;44(7-8):805-11. doi: 10.1016/j.lpm.2015.07.003. Epub 2015 Aug 13. Review. French.

PMID:
26278157
46.

Foreword: "The PI3-kinase/Akt pathway: From signaling to diseases".

Payrastre B, Cocco L.

Adv Biol Regul. 2015 Sep;59:1-3. doi: 10.1016/j.jbior.2015.07.001. Epub 2015 Jul 18. No abstract available.

PMID:
26208875
47.

Essential role of class II PI3K-C2α in platelet membrane morphology.

Valet C, Chicanne G, Severac C, Chaussade C, Whitehead MA, Cabou C, Gratacap MP, Gaits-Iacovoni F, Vanhaesebroeck B, Payrastre B, Severin S.

Blood. 2015 Aug 27;126(9):1128-37. doi: 10.1182/blood-2015-03-636670. Epub 2015 Jun 24.

48.

TOM1 is a PI5P effector involved in the regulation of endosomal maturation.

Boal F, Mansour R, Gayral M, Saland E, Chicanne G, Xuereb JM, Marcellin M, Burlet-Schiltz O, Sansonetti PJ, Payrastre B, Tronchère H.

J Cell Sci. 2015 Feb 15;128(4):815-27. doi: 10.1242/jcs.166314. Epub 2015 Jan 14.

49.

BIN1/M-Amphiphysin2 induces clustering of phosphoinositides to recruit its downstream partner dynamin.

Picas L, Viaud J, Schauer K, Vanni S, Hnia K, Fraisier V, Roux A, Bassereau P, Gaits-Iacovoni F, Payrastre B, Laporte J, Manneville JB, Goud B.

Nat Commun. 2014 Dec 9;5:5647. doi: 10.1038/ncomms6647.

PMID:
25487648
50.

Platelet PI3Kβ and GSK3 regulate thrombus stability at a high shear rate.

Laurent PA, Séverin S, Hechler B, Vanhaesebroeck B, Payrastre B, Gratacap MP.

Blood. 2015 Jan 29;125(5):881-8. doi: 10.1182/blood-2014-07-588335. Epub 2014 Nov 14.

Supplemental Content

Loading ...
Support Center